Skip to main content

Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial Images

Generic Name: ocrelizumab

This medication has been identified as Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial and is used for Multiple Sclerosis. It belongs to the drug class CD20 monoclonal antibodies and is not a controlled substance.

Images of medication

Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial medicine

Ocrevus

Generic Name
ocrelizumab
Strength
300 mg/10 mL (30 mg/mL) single-dose vial
Availability
Prescription only
Drug Class
CD20 monoclonal antibodies
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0150

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.